Literature DB >> 11880441

Ratio of two successive optical densities from the Roche HIV-1 monitor test as a measure of accuracy of estimates of human immunodeficiency virus RNA concentration.

Cheryl Jennings1, Donald J Brambilla, James W Bremer.   

Abstract

In the Roche Amplicor HIV-1 Monitor Test, the ratio of the optical density used to estimate the RNA concentration and the optical density of the preceding or the following dilution can be used to identify specimens with inaccurate results which should be retested. We present an algorithm for the identification of such results.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11880441      PMCID： PMC120231          DOI： 10.1128/JCM.40.3.1067-1068.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  12 in total

1.  Effect of errors in the sequence of optical densities from the Roche AMPLICOR HIV-1 MONITOR assay on the validity of assay results.

Authors:  D J Brambilla; S Granger; C Jennings; J W Bremer
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

2.  Multisite comparison of reproducibility and recovery from the standard and ultrasensitive Roche AMPLICOR HIV-1 MONITOR assays.

Authors:  D J Brambilla; S Granger; C Jennings; J W Bremer
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

3.  Use of HIV viral load in clinical practice: back to the future.

Authors:  M S Saag
Journal:  Ann Intern Med       Date:  1997-06-15       Impact factor: 25.391

4.  Monitoring plasma HIV-1 RNA levels in addition to CD4+ lymphocyte count improves assessment of antiretroviral therapeutic response. ACTG 241 Protocol Virology Substudy Team.

Authors:  M D Hughes; V A Johnson; M S Hirsch; J W Bremer; T Elbeik; A Erice; D R Kuritzkes; W A Scott; S A Spector; N Basgoz; M A Fischl; R T D'Aquila
Journal:  Ann Intern Med       Date:  1997-06-15       Impact factor: 25.391

5.  Evaluation of a quality assurance program for quantitation of human immunodeficiency virus type 1 RNA in plasma by the AIDS Clinical Trials Group virology laboratories.

Authors:  B Yen-Lieberman; D Brambilla; B Jackson; J Bremer; R Coombs; M Cronin; S Herman; D Katzenstein; S Leung; H J Lin; P Palumbo; S Rasheed; J Todd; M Vahey; P Reichelderfer
Journal:  J Clin Microbiol       Date:  1996-11       Impact factor: 5.948

6.  The contribution of assay variation and biological variation to the total variability of plasma HIV-1 RNA measurements. The Women Infant Transmission Study Clinics. Virology Quality Assurance Program.

Authors:  D Brambilla; P S Reichelderfer; J W Bremer; D E Shapiro; R C Hershow; D A Katzenstein; S M Hammer; B Jackson; A C Collier; R S Sperling; M G Fowler; R W Coombs
Journal:  AIDS       Date:  1999-11-12       Impact factor: 4.177

7.  The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team.

Authors:  D A Katzenstein; S M Hammer; M D Hughes; H Gundacker; J B Jackson; S Fiscus; S Rasheed; T Elbeik; R Reichman; A Japour; T C Merigan; M S Hirsch
Journal:  N Engl J Med       Date:  1996-10-10       Impact factor: 91.245

8.  Variability in repeated consecutive measurements of plasma human immunodeficiency virus RNA in persons receiving stable nucleoside reverse transcriptase inhibitor therapy or no treatment.

Authors:  J A Bartlett; R DeMasi; D Dawson; A Hill
Journal:  J Infect Dis       Date:  1998-12       Impact factor: 5.226

9.  Prognosis in HIV-1 infection predicted by the quantity of virus in plasma.

Authors:  J W Mellors; C R Rinaldo; P Gupta; R M White; J A Todd; L A Kingsley
Journal:  Science       Date:  1996-05-24       Impact factor: 47.728

10.  Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion.

Authors:  J W Mellors; L A Kingsley; C R Rinaldo; J A Todd; B S Hoo; R P Kokka; P Gupta
Journal:  Ann Intern Med       Date:  1995-04-15       Impact factor: 25.391
View more
  2 in total

1.  Use of External Quality Control Material for HIV-1 RNA Testing To Assess the Comparability of Data Generated in Separate Laboratories and the Stability of HIV-1 RNA in Samples after Prolonged Storage.

Authors:  Cheryl Jennings; Carrie G Wager; Salvatore R Scianna; Daniel J Zaccaro; Amy Couzens; John W Mellors; Robert W Coombs; James W Bremer
Journal:  J Clin Microbiol       Date:  2018-05-25       Impact factor: 5.948

2.  In vitro preclinical testing of nonoxynol-9 as potential anti-human immunodeficiency virus microbicide: a retrospective analysis of results from five laboratories.

Authors:  Brigitte E Beer; Gustavo F Doncel; Fred C Krebs; Robin J Shattock; Patricia S Fletcher; Robert W Buckheit; Karen Watson; Charlene S Dezzutti; James E Cummins; Ena Bromley; Nicola Richardson-Harman; Luke A Pallansch; Carol Lackman-Smith; Clay Osterling; Marie Mankowski; Shendra R Miller; Bradley J Catalone; Patricia A Welsh; Mary K Howett; Brian Wigdahl; Jim A Turpin; Patricia Reichelderfer
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.